J2003 Insurance Policy Changes

HCPCS J2003 is officially defined as "Injection, lidocaine hydrochloride, 1 mg." HCPCS J2003 is referenced in 6 tracked payer policy changes from Capital Blue Cross, Aetna, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J2003 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Capital Blue Cross · Effective Mar 1, 2026High impact
AB2026-01-001 Updates and new information
Effective March 1, 2026, a number of codes newly require preauthorization for Commercial and Medicare Advantage members, including 20985, 22100 and 27860, and HCPCS code H0032 will be denied because the service is not provided directly to members. Codes C1605, C1721 and others no longer require preauthorization effective February 1, 2026, Evolent updated its CT, MRI, PET and cardiac imaging policies effective March 1, 2026, and TurningPoint accepts listed substitute codes for a limited group of musculoskeletal surgical procedures effective February 1, 2026. Effective for claims processed on or after March 1, 2026, facility claims with modifiers 59, XE, XP, XS and XU that do not meet the CMS criteria to bypass an NCCI procedure-to-procedure edit will be rejected, and physical medicine code 97140 is not separately reimbursed when billed with chiropractic manipulative treatment in the same anatomical region.
Aetna · Identified Oct 6, 2026Medium impact
Viscosupplementation (CPB 0179, reviewed 2026-09-02)
Aetna Clinical Policy Bulletin 0179 covers viscosupplement (hyaluronate) injections for knee osteoarthritis under commercial medical plans, and considers all other indications experimental, investigational, or unproven. Initial approval requires radiographic evidence of knee osteoarthritis or at least five listed signs and symptoms, knee pain that interferes with functional activities, an inadequate response or adverse effects with non-pharmacologic treatment, an inadequate response, intolerance or contraindication to an analgesic trial for at least 3 months, an inadequate response, intolerance or contraindication to intra-articular steroid injections for at least 3 months, and no total knee replacement scheduled within 6 months of starting treatment. Continuation requires improvement in pain and functional capacity after prior injections and at least 6 months since the last injection in the prior completed series. the policy was last reviewed 09/02/2026, and its next review is listed for 01/28/2027.
Aetna · Identified Aug 16, 2026Medium impact
Nebulizers (CPB 0065, reviewed 2026-03-18)
Aetna covers small volume nebulizers and related compressors for listed indications, including antibiotics for cystic fibrosis or bronchiectasis, beta-adrenergics and other inhaled drugs for COPD, dornase alfa for cystic fibrosis or primary ciliary dyskinesia, and epinephrine for croup. Large volume nebulizers are considered medically necessary for pentamidine, bronchiectasis, cystic fibrosis, tracheobronchial stents, and tracheostomy, and ultrasonic nebulizers are considered medically necessary only for tobramycin (Tobi) delivery in members with cystic fibrosis who meet the criteria for a standard nebulizer and the additional criteria in the policy. Aetna considers these nebulizers and related equipment experimental, investigational, or unproven for all other indications, including nebulized corticosteroids for nasal polyps and viral wheezing, nebulized lidocaine, and nebulized magnesium for pediatric asthma.
Aetna · Identified Aug 15, 2026Medium impact
Headaches: Nonsurgical Management (CPB 0462, reviewed 2026-07-23)
Aetna covers intravenous dihydroergotamine (DHE) for status migrainosus, for other intractable severe migraine attacks unresponsive to analgesics and triptans, and for cluster headache attacks that do not respond to oxygen or triptans, when given in the emergency room, hospital or urgent care setting, and covers it for medication overuse headache in the inpatient setting. Aetna also covers intramuscular ketorolac for short-term management of acute migraine (5 days or less), intramuscular and intravenous steroids and intravenous magnesium for acute migraines, caffeine citrate infusion for post lumbar puncture headache when the member is unable to take caffeine orally, and eptinezumab-jjmr (Vyepti) for preventive migraine treatment in an adult when the criteria are met. Aetna considers cranio-sacral therapy, intra-oral splints for tension-type headaches, IV DHE for other headache types, and a list of other nonsurgical migraine and cluster headache interventions experimental, investigational or unproven.
Aetna · Identified Aug 14, 2026Medium impact
Eagle's and Ernest Syndrome (CPB 0400, reviewed 2026-06-30)
Aetna's Clinical Policy Bulletin 0400 considers styloidectomy medically necessary for Eagle's syndrome only when specific criteria are met, with separate criteria for the non-vascular form and the vascular form linked to carotid artery dissection. Radiofrequency thermoneurolysis is considered experimental, investigational or unproven for Eagle's and Ernest syndromes, and styloidectomy for jugular vein stenosis, for carotid stenosis without dissection, and for other listed indications such as tinnitus, headache and neck pain is also considered experimental, investigational or unproven.
Blue Cross and Blue Shield of Louisiana · Identified Jun 20, 2026Medium impact
Network News - 3rd Quarter 2024
Already effective October 1, 2024, Blue Cross and Blue Shield of Louisiana added the listed CPT and HCPCS codes to its Diagnostic and Therapeutic Services code range, including 90624, 0476U and J2002. Medical policies with effective dates from August 12 through October 20, 2024 were updated or newly issued, including policy 00006 Autologous Chondrocyte Implantation for Focal Articular Cartilage Lesions and policy 00236 Axial Lumbar Interbody Fusion. The updated provider manuals include policy changes and other reimbursement changes that apply to services on and after January 1, 2025.

Watch J2003

Get one email when a payer policy names J2003, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

REFERENCE DATA

Payers with rules3

Payers requiring prior auth3

CalViva Health · Effective December 31, 2025
Prior authorization required
CalViva Health CMS-0057-F prior authorization requirements
Centene · Effective December 31, 2025
Prior authorization required
Sunshine Health Title XIX, Title XXI, Managed Medical Assistance CMS-0057-F prior authorization requirements
Community Health Plan of Imperial Valley · Effective December 31, 2025
Prior authorization required
Community Health Plan of Imperial Valley CMS-0057-F prior authorization requirements

FREQUENTLY ASKED QUESTIONS

Does CalViva Health require prior authorization for J2003?

CalViva Health lists J2003 on CalViva Health CMS-0057-F prior authorization requirements for medicaid managed plans (list dated December 31, 2025). Verify with the payer before scheduling.

Does Centene require prior authorization for J2003?

Centene lists J2003 on Sunshine Health Title XIX, Title XXI, Managed Medical Assistance CMS-0057-F prior authorization requirements for medicaid managed plans (list dated December 31, 2025). Verify with the payer before scheduling.

Does Community Health Plan of Imperial Valley require prior authorization for J2003?

Community Health Plan of Imperial Valley lists J2003 on Community Health Plan of Imperial Valley CMS-0057-F prior authorization requirements for medicaid managed plans (list dated December 31, 2025). Verify with the payer before scheduling.

What insurance policy changes affect HCPCS J2003?

There are 6 tracked policy changes affecting HCPCS J2003, including updates from Capital Blue Cross, Aetna, Blue Cross and Blue Shield of Louisiana. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for HCPCS J2003?

Payers that have issued tracked updates for HCPCS J2003 include: Capital Blue Cross, Aetna, Blue Cross and Blue Shield of Louisiana.

How do I get notified when HCPCS J2003 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to HCPCS J2003. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for HCPCS J2003?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

See every payer rule for J2003

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for J2003 in one place.

See every payer rule

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

AB2026-01-001 Updates and new information

Viscosupplementation (CPB 0179, reviewed 2026-09-02)

Nebulizers (CPB 0065, reviewed 2026-03-18)

Headaches: Nonsurgical Management (CPB 0462, reviewed 2026-07-23)

Eagle's and Ernest Syndrome (CPB 0400, reviewed 2026-06-30)

Network News - 3rd Quarter 2024

Prior authorization required

Prior authorization required

Prior authorization required

Does CalViva Health require prior authorization for J2003?

Does Centene require prior authorization for J2003?

Does Community Health Plan of Imperial Valley require prior authorization for J2003?

What insurance policy changes affect HCPCS J2003?

Which payers have updated policy for HCPCS J2003?

How do I get notified when HCPCS J2003 policy changes?

Why do payers change policies for HCPCS J2003?